100 results
Page 2 of 5
8-K
EX-99.1
mcv 3acpw
9 May 23
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:06pm
8-K
EX-10.1
2t92vp1h lgcc1vg
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
ixqk melrx
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
064pagx1
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
so29cfa4gydyr
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-4.2
4lbb vr6ck9ettp
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-1.1
89fim63 dp
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
EX-99.1
m9z4xuf
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
8-K
ehtcsj 4bdhq
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
hqrhg6c4re3ocz4pdfu5
30 Mar 22
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
t4ya646q3h fd3k
28 Mar 22
Soleno Therapeutics Announces Proposed Underwritten Public Offering
4:59pm
424B5
ab2gnfgsnd3 ckti2
28 Mar 22
Prospectus supplement for primary offering
4:53pm